6-K: Novo Nordisk A/S - Share Repurchase Programme
6-K: Novo Nordisk A/S - Share Repurchase Programme
6-K: Novo Nordisk A/S - Share Repurchase Programme
6-K: Novo Nordisk A/S - Share Repurchase Programme
6-K: Novo Nordisk A/S - Share Repurchase Programme
SD: Specialized disclosure report
6-K: Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons
6-K: Once-Weekly and Once-Monthly Mim8 Demonstrate Superior Reduction of Treated Bleeding Episodes Compared to On-Demand and Prior Prophylaxis Treatment in People with Haemophilia a in the Frontier 2 Trial
6-K: Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons
6-K: Novo Nordisk A/S - Share Repurchase Programme
6-K: Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons
6-K: Novo Nordisk A/S Purchases B Shares Worth Dkk 5,428 Million from Novo Holdings A/S Under the 2024 Share Repurchase Programme
6-K: Trading in Novo Nordisk Shares by Board Members, Executives and Associated Persons
6-K: Financial Report for the Period 1 January 2024 to 31 March 2024
6-K: Novo Nordisk A/S - Share Repurchase Programme
6-K: Novo Nordisk A/S – Total Number of Voting Rights and Share Capital in Novo Nordisk A/S as of 26 April 2024
6-K: Articles of Association of Novo Nordisk A/S
6-K: Novo Nordisk A/S – Reduction of the Share Capital
Novo-Nordisk A/S | 6-K: Novo Nordisk A/S - Share Repurchase Programme
Novo-Nordisk A/S | 6-K: Novo Nordisk A/S - Share Repurchase Programme
No Data